Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Instil Bio Inc (TIL)

  • Event
  • June 13, 2022, 21:08 UTC
  • 20
  • 1 comments

(99% Neutral) Instil Bio, Inc. (TIL) Announces Business Combination

Comment Full text

Intra-Cellular Therapies Inc (ITCI)

  • Event
  • June 13, 2022, 21:01 UTC
  • 20
  • 1 comments

(99% Neutral) Intra-Cellular Therapies, Inc. (ITCI) Announces Regulatory Update

Comment Full text

Zentalis Pharmaceuticals (ZNTL)

  • Event
  • June 13, 2022, 21:00 UTC
  • 20
  • 1 comments

(50% Neutral) ZENTALIS PHARMACEUTICALS, INC. (ZNTL) Announces Regulatory Update

Comment Full text

CRISPR Therapeutics (CRSP)

  • Event
  • June 13, 2022, 20:58 UTC
  • 20
  • 1 comments

(99% Neutral) CRISPR THERAPEUTICS AG (CRSP) Announces New Board Appointment

Comment Full text

Urogen Pharma Inc (URGN)

  • Event
  • June 13, 2022, 20:55 UTC
  • 21
  • 1 comments

(99% Neutral) UROGEN PHARMA LTD. (URGN) Announces Executive Changes

Comment Full text

Lyell Immunopharma (LYEL)

  • Event
  • June 13, 2022, 20:54 UTC
  • 20
  • 1 comments

(99% Neutral) Lyell Immunopharma, Inc. (LYEL) Announces Business Combination

Comment Full text

Harrow Health Inc (HROW)

  • Event
  • June 13, 2022, 20:36 UTC
  • 20
  • 1 comments

(99% Neutral) HARROW HEALTH, INC. (HROW) Announces Regulatory Update

Comment Full text

Silverback Therapeutics Inc (company was transformed to ARS Pharmaceuticals (NASDAQ : SPRY) (SBTX)

  • Event
  • June 13, 2022, 20:32 UTC
  • 19
  • 1 comments

(99% Neutral) Silverback Therapeutics, Inc. (SBTX) Files Form 8-K

Comment Full text

ADMA Biologics Inc (ADMA)

  • Event
  • June 13, 2022, 20:30 UTC
  • 20
  • 1 comments

(99% Neutral) ADMA BIOLOGICS, INC. (ADMA) Announces Business Combination

Comment Full text

iTeos Therapeutics (ITOS)

  • Event
  • June 13, 2022, 20:21 UTC
  • 20
  • 1 comments

(99% Neutral) iTeos Therapeutics, Inc. (ITOS) Files Form 8-K

Comment Full text
  • Previous
  • 579
  • 580
  • 581
  • 582
  • 583
  • Next

Search

News categories

  • Technical Exchange News(12514)
  • Event(6229)
  • SEC News(286630)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(162338)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin